Nanjing Vazyme Biotech Co., Ltd. (688105.SS) SHH

25.85

-0.18(-0.69%)

Updated at August 19 11:29AM

Currency In CNY

Valuation

Market Cap8.8B
Enterprise Value9.06B
P/E Ratio-480.43
PEG Ratio26.74
Price/Sales Ratio7.58
Price/Book Ratio2.64
Enterprise/Revenue8.03
Enterprise/EBITDA153.74

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-0.02
Operating Margin-0.05

Management Effectiveness

Return On Assets-0
Return On Equity-0.01

Income Statement

Revenue1.38B
Revenue/Share3.41
Gross Profit963.54M
EBITDA121.51M
Net Income-18.09M
Diluted EPS-0.05

Balance Sheet

Total Cash2.91B
Total Cash/Share7.31
Total Debt1.09B
Total Debt/Equity0.28
Current Ratio3.33
Book Value Per Share9.81

Price History

52-Week Change27.28
52-Week High29.69
52-Week Low16.85
Moving Average 50 Days23.67
Moving Average 200 Days23.05

Statistics

Average Volume2.57M
Shares Outstanding397.73M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.18
Trailing Annual Dividend Yield0.7
Payout Ratio-3.39
Last Split FactorN/A
Last Split DateN/A